Company · Healthcare
Wearable monitoring system for Parkinson's disease
Melbourne, VIC
Every investor coverage indicates participated in a round Global Kinetics raised.
Companies Global Kinetics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr David Atkins | Brandon Capital, Brandon BioCatalyst | |
| Zach Henderson | Chief Executive Officer | Brandon Capital, Brandon BioCatalyst |
| Karen Krygier | Senior Director Clinical Affairs | Brandon BioCatalyst portfolio |
| David Buché | Vice President Sales and Marketing, General Manager US RPM Business | Brandon BioCatalyst portfolio |
Stories naming Global Kinetics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Global Kinetics, a Melbourne-based digital neurology company, names Zach Henderson its chief executive; Leighton Read shifts to non-executive chair and BioScience Managers' David Atkins joins the board.
Global Kinetics, a Melbourne-based digital health company focused on neurology, has appointed industry veteran Zach Henderson, formerly of Glooko, as chief executive, while also adding BioScience Managers' David Atkins to its board.
Parkinson's monitoring company Global Kinetics is launching its PKG wearable into the US remote physiologic monitoring market and has recruited David Buché as vice president of sales to lead the American commercial push.
Brandon Capital's blog reports a first close of $210 million toward its $250 million MRCF 5 biotech fund, with super funds and CSL backing, and recalls past portfolio sales of Spinifex and Fibrotech.
Brandon Capital's Medical Research Commercialisation Fund has launched its fifth vehicle, MRCF5, completing a NZ$224 million first close and targeting NZ$267 million, while recalling earlier portfolio exits of Elastagen, Spinifex and Fibrotech.
Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Startup Daily
Ikkiworks, a Sydney medtech startup, received a $25,000 NSW government MVP grant for its robot helping seriously ill children at home, alongside mentions of other medtech grants.